Literature DB >> 2468114

Kynurenic acid is present in the rat brain and its content increases during development and aging processes.

F Moroni1, P Russi, V Carlá, G Lombardi.   

Abstract

The content of kynurenic acid, a tryptophan (TRP) metabolite which acts as an antagonist of the excitatory amino acid receptors, was measured in the brain, blood, liver and kidney of rats of different ages, using a sensitive and specific method based on ion exchange chromatography and high-performance liquid chromatography (HPLC). In a portion of the cortex of these animals the content of serotonin (5-HT), 5-hydroxyindole-3-acetic acid (5-HIAA) and of TRP was also measured using HPLC and electrochemical detection. The brain content of kynurenic acid was extremely low during the first week of life measuring 15 +/- 3 pmol/g protein (mean +/- S.E.M.), was found to be 320 +/- 31 at 3 months and continued to increase reaching levels of 747 +/- 116 at 18 months of age. Aging failed to change kynurenate content in the liver and kidney while blood kynurenate concentration increased from 28 +/- 5 (pmol/ml) in 3 months old rats to 65 +/- 10 in those 18 months old. The accumulation of kynurenate in the brain was not due to an increased availability of TRP to the central nervous system of aged rats. In fact, the cortical content of this amino acid was slightly lower in animals 18 months old than in those 3 months old. These large changes of the brain content of an electrophysiologically active TRP metabolite such as kynurenic acid could help explain the functional differences present in the brain of newborn and aged animals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2468114     DOI: 10.1016/0304-3940(88)90285-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

Review 1.  Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery.

Authors:  Flavio Moroni; Andrea Cozzi; Maria Sili; Guido Mannaioni
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

2.  Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.

Authors:  Gregory Oxenkrug
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

3.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

4.  Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Sara K Olsson; Martin Samuelsson; Peter Saetre; Leif Lindström; Erik G Jönsson; Conny Nordin; Göran Engberg; Sophie Erhardt; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2010-05       Impact factor: 6.186

5.  L-alpha-aminoadipate inhibits kynurenate synthesis in rat brain hippocampus and tissue culture.

Authors:  Y F Chang; R K Cauley; J D Chang; V V Rao
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

6.  Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.

Authors:  Cynthia O Akagbosu; Gretchen C Evans; Danielle Gulick; Raymond F Suckow; David J Bucci
Journal:  Schizophr Bull       Date:  2010-12-20       Impact factor: 9.306

7.  Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism.

Authors:  Gregory F Oxenkrug; Valeria Navrotskaya; Lyudmila Voroboyva; Paul Summergrad
Journal:  Fly (Austin)       Date:  2011-10-01       Impact factor: 2.160

8.  Effect of aging on dopamine metabolism in the rat cerebral cortex: a regional analysis.

Authors:  F Godefroy; M H Bassant; Y Lamour; J Weil-Fugazza
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 9.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2009-11-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.